Association between circulating cytokines expression patterns and outcomes to immune-checkpoint (ICI)–based regimens in metastatic renal cell carcinoma (mRCC).
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2024.42.16_suppl.4547
Abstract: 4547 Background: ICI combinations (combos) in the form of dual ICI or ICI plus tyrosine kinase inhibitors (TKI) combos currently represent the most effective therapies in mRCC patients (pts). However, there is an unmet need… read more here.
Keywords: risk; association; ici combos; expression ... See more keywords